Litigation Details for CIGNA CORPORATION v. CELGENE CORPORATION (E.D. Pa. 2021)
✉ Email this page to a colleague
CIGNA CORPORATION v. CELGENE CORPORATION (E.D. Pa. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-01-08 |
| Court | District Court, E.D. Pennsylvania | Date Terminated | 2021-05-24 |
| Cause | 15:1 Antitrust Litigation | Assigned To | KAREN S. MARSTON |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 6,045,501; 6,281,230; 6,315,720; 6,555,554; 6,561,976; 6,561,977; 6,755,784; 6,869,399; 7,119,106; 7,141,018; 7,189,740; 7,230,012; 7,465,800; 7,468,363; 7,668,730; 7,855,217; 7,959,566; 7,968,569; 8,204,763; 8,288,415; 8,315,886; 8,404,717; 8,530,498; 8,626,531; 8,648,095; 8,741,929; 9,056,120; 9,101,621; 9,101,622 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in CIGNA CORPORATION v. CELGENE CORPORATION
Details for CIGNA CORPORATION v. CELGENE CORPORATION (E.D. Pa. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-01-07 | 1 | Complaint (Attorney) | preventing the Revlimid ‘501 Patent 6,045,501 4-Apr-00 …800 Patent, ‘217 Patent, ‘569 Patent, ‘498 Patent, ‘095 Patent, ‘621 Patent, and the ‘622 Patent.100 … ‘800 Patent, ‘217 Patent, ‘569 Patent, ‘498 Patent, ‘095 Patent, ‘621 Patent, and ‘622 Patent.101 … ‘800 Patent, ‘217 Patent, ‘569 Patent, ‘498 Patent, ‘095 Patent, ‘621 Patent, and ‘622 Patent.110 This…800 Patent, ‘217 Patent, ‘569 Patent, ‘498 Patent, ‘095 Patent, ‘621 Patent, and the ‘622 Patent.112 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
